Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Unit’s Plea Over Vioxx Investigation Accepted by Judge
Bloomberg
Thursday, April 19, 2012 - 11:42am
tags:
Merck, Vioxx
Bristol-Myers shares likely to pull back after conference, says MKM Partners
The Fly on the Wall
Thursday, April 19, 2012 - 11:42am
tags:
Bristol-Myers Squibb
AstraZeneca Will Tumble If New Dutoprol Drug Fails
Seeking Alpha
Thursday, April 19, 2012 - 10:58am
tags:
AstraZeneca, Dutoprol, Amgen, Bristol-Myers Squibb, GSK, Merck, Targacept, antihypertensives
Johnson & Johnson Will Tumble On Risperdal Lawsuit, Bad PR
Seeking Alpha
Thursday, April 19, 2012 - 10:41am
tags:
JNJ, Risperdal
Merck says it won its 5th Fosamax lawsuit
Yahoo/AP
Thursday, April 19, 2012 - 10:38am
tags:
Merck, Fosamax
Human Genome jumps 109%, above GSK's $13 per share offer price
Yahoo/Fly on the Wall
Thursday, April 19, 2012 - 10:37am
tags:
Human Genome Sciences, GSK
Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial
Bloomberg
Thursday, April 19, 2012 - 10:36am
tags:
Boehringer Ingelheim, hepatitis C, BI 201335, protease inhibitors, nucleoside polymerase inhibitor, BI 207127
EU OKs J&J's $21.3B Synthes Takeover: Hot Trends
TheStreet.com
Thursday, April 19, 2012 - 10:35am
tags:
Europe, JNJ, Synthes, M&A
Human Genome Sciences Rejects $2.59 Billion Offer From GlaxoSmithKline
NY Times, NY
Thursday, April 19, 2012 - 10:34am
tags:
Human Genome Sciences, GSK, M&A
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wednesday, April 18, 2012 - 12:11pm
tags:
BB1608, Boston Biomedical, Dainippon Sumitomo, cabozantinib, Exelixis, ONYX Pharmaceuticals, Carfilzomib, Medivation, Astellas, Enzalutamide, Ariad Pharmaceuticals, Ponatinib, Bayer, regorafenib, Oncovex, Amgen, Roche, Genentech, T-DM1, Immunogen, Aveo, tivozanib, Zaltrap, Sanofi, Regeneron
Is Pfizer Dropping Out of the Baby Business?
Wall St. Cheat Sheet
Wednesday, April 18, 2012 - 12:03pm
tags:
Pfizer, infant nutrition, Mead Johnson, Danone SA, Abbott Laboratories
Arena Pharma's Own Data Point to Weight-Loss Drug Rejection
TheStreet.com
Wednesday, April 18, 2012 - 11:43am
tags:
obesity, Arena, lorcaserin
Eli Lilly Will Sink If Solanezumab Fails
Seeking Alpha
Wednesday, April 18, 2012 - 11:42am
tags:
solanezumab, Eli Lilly, GSK, JNJ, Pfizer, Sanofi, Alzheimer's disease
A Reasoned Case For Avanafil Approval
Seeking Alpha
Wednesday, April 18, 2012 - 11:40am
tags:
Avanafil, Vivus, Pfizer, Sanofi, erectile dysfunction
Endocyte Gets Big Deal But More Validation Needed
Seeking Alpha
Wednesday, April 18, 2012 - 11:39am
tags:
Merck, Endocyte, EC145, ovarian cancer
Abbott beats Street, lifts 2012 forecast
Reuters
Wednesday, April 18, 2012 - 11:38am
tags:
Abbott Laboratories, earnings
MAP Pharmaceutical: Timeline Of The NDA Resubmission
Seeking Alpha
Wednesday, April 18, 2012 - 10:13am
tags:
MAP Pharmaceuticals, Levadex, FDA
Roche not to extend tender offer for Illumina
Markewatch
Wednesday, April 18, 2012 - 10:02am
tags:
Roche, M&A, Illumina
Medivir Announces TMC435 in an Expanded Clinical Collaboration
Yahoo
Wednesday, April 18, 2012 - 9:14am
tags:
Medivir, TMC435, Janssen, Bristol-Myers Squibb, daclatasvir, hepatitis C
Popular J.&J. Drugs May Not Return Until 2013
NY Times, NY
Wednesday, April 18, 2012 - 9:13am
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.